Ask Us
Register
Monitoring Medicines for over 2,573,000 Members
Australia
Brasil
Deutschland
España
France
United Kingdom
United States
English
Español
What is MediGuard?
Drugs A to Z
Conditions
Research
About Us
Recent Pages:
Safety Alert: Lisinopril--Recall of Two Lots of Lisinopril 10 mg
/
Advil satisfaction and usage data | Monitoring more than 140,000 patients | Drug safety information
/
Safety Alert: Fentanyl--Recall of Two Lots of FENTANYL (also sold as DURAGESIC) 50 mcg/hr Transdermal System Patches
Please correct the highlighted fields below.
Alerts for
Risedronic Acid
Title
Date Published
Source
FDA Reviewing of Oral Bisphosphonates and Potential Increased Risk of Esophageal Cancer
2011-07-22
Healthcare Professionals Advised Of Potential Risk Of Atypical Fractures of the Thigh With Bisphosphonates
2011-06-07
Europäische Arzneimittelbehörde warnt vor Knochenbrüchen am Oberschenkel durch Osteoporose-Medikamente
2011-05-19
Benefits of Bisphosphonates Continue to Outweigh Risks
2011-05-06
La Agencia Europea De Medicamentos Revisa La Seguridad De Los Bisfosfonatos
2011-05-02
Europe-wide Review Shows Insufficient Evidence To Prove Link Between Oral Biphosphonates And Oesophageal Cancer
2010-12-14
FDA Updates Prescribing Information to Warn of Possible Fracture Risk With Osteoporosis Drugs
2010-10-13
FDA Issues Statement on Possible Increased Risk of Rare Bone Fractures with Long-Term Bisphosphonate Use
2010-09-19
Update on FDA Safety Review of Bisphosphonates
2008-11-14
New Consumer Guide for Patients
2008-07-03
FDA Communication Regarding Musculoskeletal Pain
2008-01-07
Early communication of ongoing safety review
2007-10-01
See alerts for all drugs